Moreover, CEST contrasts have been shown to be sensitive to histopathological features of gliomas such as tumor grade, isocitrate-dehydrogenase (IDH) -mutations and MGMT promotor status [19, 20, 26, 27, 43]. Here, IDH3A is linked to glioma.